Figure 3From: Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancerComparison of tumor89Zr-bevacizumab uptake (SUV peak ) on days 4 and 7. A correlation coefficient (r s ) of 1 (P < 0.001) was found.Back to article page